Could customizing radiation doses improve prostate cancer treatment?
Disease control
Recruiting now
This study tests whether giving a personalized dose of a radioactive drug (177Lu-PSMA-617) based on kidney radiation exposure is safer and more effective than the standard fixed dose. About 60 men with advanced prostate cancer that no longer responds to hormone therapy will recei…
Phase: PHASE1 • Sponsor: Jean-Mathieu Beauregard • Aim: Disease control
Last updated May 05, 2026 11:56 UTC